Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gilead asks FDA again to approve twice-a-year HIV-fighting drug By: San Francisco Business Times via Business Journals June 27, 2022 at 19:37 PM EDT The drug, called lenacapavir, was rejected by the FDA in February because of issues with the vials holding the injectable drug. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Gilead asks FDA again to approve twice-a-year HIV-fighting drug By: San Francisco Business Times via Business Journals June 27, 2022 at 19:37 PM EDT The drug, called lenacapavir, was rejected by the FDA in February because of issues with the vials holding the injectable drug. Read More >>
